Medicare no longer pays for COVID-19 vaccines, and monoclonal antibody treatment rendered to MA plans patients

If you administer COVID-19 vaccines and monoclonal antibody treatment to patients enrolled under commercial Medicare Advantage plans, please bill such services to these plans. For example, if your patient is a Medicare beneficiary, but his/her primary payer is Aetna, Aetna must process claims for COVID-19 vaccines. 

You need to be logged in to view the rest of the content. Please . Not a Member? Join Us